key: cord-0986571-skm6ub62
authors: Nazneen, Arifa; Sultana, Rebeca; Rahman, Mahmudur; Rahman, Mahbubur; Qadri, Firdausi; Rimi, Nadia Ali; Hossain, Md. Kamal; Alam, Muhammad Rashedul; Rahman, Mustafizur; Chakraborty, Nitai; Sumon, Shariful Amin; Hussain, Enayet; Hasan, Mohammad Zakiul; Khan, Sazzad Hossain; Prodhan, Md. Hasnatuzzaman; Bablu, Arifur Rahman; Banik, Kajal Chandra; Fahad, Md. Habibullah; Akhtar, Marjahan; Satter, Syed Moinuddin; Ahmed, Shahriar; Rahman, Ahmed Ehsanur; Bhuiyan, Taufiqur Rahman; Alamgir, A.S.M.; Arifeen, Shams El; Shirin, Tahmina; Banu, Sayera; Flora, Meerjady Sarbrina
title: Prevalence of COVID-19 in Bangladesh, April to October 2020 - A cross-sectional study
date: 2021-10-14
journal: IJID Regions
DOI: 10.1016/j.ijregi.2021.10.003
sha: a7644b5d8536f60ba28ac7f0ac2ac43bf91ca419
doc_id: 986571
cord_uid: skm6ub62

Objective We aimed to estimate the proportion of symptomatic and asymptomatic laboratory-confirmed COVID-19 cases among Bangladesh's population. Design We conducted a cross-sectional survey in Dhaka City and other districts of Bangladesh between April 18 and October 12, 2020. We randomly selected 32 districts outside Dhaka, where one village and one mahalla from each district, and from Dhaka City, selected 25 mahallas. From each village or mahalla, we enrolled 120 households through systematic random sampling. Results A total of 44,865 individuals were interviewed from 10,907 households. The majority (70%, n-31488) of the individuals were <40 years of age. Almost half of the individuals (49%, n=21,888) reported >4 members in their households. We estimated, 12.6% (n=160) of the households had ≥1 COVID-19 infected individuals, among them, 0.9% (n=404) individuals had at least one COVID-19 like symptom at the national level. Prevalence of COVID-19 was 6.4% among the general population. Among the COVID-19 positive individuals, 87% were asymptomatic. Conclusions The substantial high number of asymptomatic cases all over Bangladesh suggests that community-level containment and mitigation measures to combat COVID-19. Future studies to understand the transmission capability could help to define mitigation and control measures.

Globally, as of October 5, 2021, a total of 236,132,082 confirmed cases and 4,822,472 deaths had been identified worldwide (World Health Organization, 2021) . The COVID-19 was first reported in Bangladesh on March 8, 2020 (GARDAWORLD, 2020). As of October 8, 2021, a total of 1,561,463 confirmed cases had been identified in Bangladesh, including 27,654 deaths (DGHS, 2021) . Until recently, D614 G mutation in spike glycoprotein was most common (98 %) variant of COVID-19 in Bangladeshi isolates. Most of the available studies showing the prevalence of COVID-19 included data from hospitals and medical center facilities, and estimates were based on patients visiting the facilities (Cummings et al., 2020; Liang et al., 2020; McMichael et al., 2020; Spellberg et al., 2020) . In Bangladesh, most of the COVID-19 studies conducted using hospital-based data or the government database Mannan et al., 2021; M. H. B. Siam et al., 2021) . Many of the studies in this country were reported findings from specific hotspots or specific districts Page 5 of 27 (Ali et al., 2021; Islam et al., 2021; Islam & Noman, 2020; Z. S. Siam et al., 2021) . Furthermore, presentation of countrywide COVID-19 situation was mostly based on mathematical modelling (Hridoy et al., 2020; Sarkar et al., 2021) . Thus, information on the prevalence of COVID-19 from community-based studies remains limited. In 2020, diagnostic testing of COVID-19 was mainly available to government health facilities and laboratories (Carlos del Rio & Malani, 2020; Paules et al., 2020) . Furthermore, until recently in Bangladesh, testing was prioritized for persons who showed symptoms (Islam & Noman, 2020) . These results are an underestimation of the true prevalence of this disease, since studies already noted a considerable number of asymptomatic cases in many (Anderson et al., 2020; Bai et al., 2020; Gao et al., 2020; Kim et al., 2020) countries including Bangladesh (Ali et al., 2021; Chowdhury et al., 2021; Mannan et al., 2021) along with symptomatic cases of COVID-19. Both symptomatic and asymptomatic COVID-19 cases are capable of spreading the disease by person to person transmission . Studies identified that transmission from asymptomatic individuals occurred during the incubation period (a week before the onset of COVID-19 illness) Rothe et al., 2020; Yu et al., 2020) and similar viral load was noted from both symptomatic and asymptomatic cases (Zou et al., 2020) .

Reporting of infectious diseases, including COVID-19, is challenging, as individuals with mild symptoms do not seek care from healthcare facilities, let alone the asymptomatic individuals, and the actual burden of the disease remains uncovered (Gibbons et al., 2014; Munster et al., 2020) .

Determining the prevalence of symptomatic and asymptomatic COVID-19 cases at the community level is critically important to estimate the true burden of COVID-19. This information can help redefine the current public health containment, mitigation and long-term Page 6 of 27 prevention strategies. Therefore, we aimed to estimate the proportion of symptomatic and asymptomatic laboratory-confirmed COVID-19 cases among the population of Bangladesh.

We conducted the community-based cross-sectional survey all over the country, including the Dhaka City Corporation area, between April 18 and October 12, 2020. We randomly selected 32 districts out of the 64 districts of Bangladesh (Figure-2). From each selected district, we randomly selected one village (the smallest geographical unit of the rural area) and one mahalla (the smallest geographical unit of urban area) for data collection. Dhaka City was purposively selected from Dhaka district as the capital city of Bangladesh and the hotspots of COVID-19 cases. For the Dhaka City Corporation, we randomly selected 25 wards (i.e., the administrative and geographical unit of the City Corporation area) out of the 129 wards (Dhaka North City Corporation, 2019; Dhaka South City Corporation, 2019). From each selected ward, we randomly selected one mahalla, from each selected mahalla and village, we enrolled 120 households through systematic random sampling.

We collected information on the total number of households of each selected village/ mahallafrom the local administrative offices and divided the total number of households by the number of households required to be enrolled (i.e., 120) to determine the sampling interval. If the selected village/mahalla had less than 120 households, an adjacent village was also selected to enroll the required number of households. We randomly selected a side of the village/mahalla Page 7 of 27 (North, South, East, or West) to select the entry point. To select the first household, we provided numbers to the first nine households starting from the closest household of the selected entry point, randomly took a Bangladeshi Taka (BDT) and used the last digit of its serial number (from 1-9), and selected the first household in that side. Then we kept selecting households towards the direction of the opposite side (e.g., from North to South) with the calculated sampling interval and repeatedly carried out the same process of selection from another side of the village/ mahalla until the sample size was reached. If any household refused to participate, we selected the next household.

The study team interviewed an adult member of every enrolled household. They collected data on socio-demographics and illness related to COVID-19 of all household members of the selected household. The team conducted face-to-face interviews using a structured questionnaire with questions on symptoms, the onset of illness, smoking history, BCG vaccine status, comorbid conditions, number of rooms in households, and information on bathroom sharing. The team also collected the GPS (global positioning system) coordinates of all the selected households. From the interviews, the team defined the households as symptomatic and asymptomatic based on the presence of individuals with any COVID-19 symptoms (fever, cough, sore throat, and dyspnoea). The team also followed up on the asymptomatic COVID-19 positive cases for up to two weeks to ascertain their asymptomatic status.

Any member of the 120 households reporting any symptoms (fever or cough or sore throat or shortness of breathing/dyspnoea) relevant to COVID-19 within the last seven days were enrolled as a symptomatic household.

Every 10th household of the asymptomatic households (reporting no symptom within the last seven days for all members) within each village/mahalla was selected as an asymptomatic household for sample collection. The first household for selecting the asymptomatic household was the 10th household, and at the 10th interval until 10 asymptomatic households were selected.

If any member of the 10th household reported any symptom relevant to COVID-19 (symptomatic household) or the asymptomatic household refused to provide a sample, the next household was selected.

All individuals of symptomatic households and selected asymptomatic households (every 10 th ) were eligible for sample collection. The team collected samples from the participants of those households present on the day of the survey and provided consent for sample collection. For the absent individuals of the households, the team communicated with them over the phone if they are willing to provide the sample. Teams also collected samples beyond duty hour or the next day if any participant wanted to provide specimens later. 

We summarized all categorical variables using frequency and percentage. For each sampling stage, we estimated the selection probability of sampling units using the existing sampling frame.

We then multiplied all the selection probabilities obtained from each stage to estimate the selection probability for each selected individual. We then estimated individual-level sampling weight by taking the inverse of the selection probabilities. Finally, we normalized the weights and used them to estimate the parameters. We estimated the prevalence of COVID-19 cases with a 95% confidence interval adjusting for design weight and clustering effects. For analysis we used STATA, version 13.0.

The Research Review Committee and the Ethical Review Committee of icddr,b approved the study protocol. We obtained informed written consent from all the respondents before enrollment and data collection.

Page 10 of 27 A total of 44,865 individuals were interviewed from 10,907 households ( Figure 1 ). The majority (70%, n=31488) of the individuals were <40 years of age (Table 1) . Almost half of the individuals (49%, n=21,888) reported >4 members in their households (Table 1) . Fifty-four percent (n=24442) of individuals lived in houses with ≤2 rooms. Among the 10,907 households, 488 were symptomatic, and we were able to enroll 477 symptomatic households with 655 symptomatic and 1442 asymptomatic individuals (Figure 1 ), and 350 individuals tested positive for COVID-19. Among the 10,419 asymptomatic households, we enrolled 903 asymptomatic households with 3,470 asymptomatic individuals (Figure 1) . A total of 3667 individuals were tested to confirm COVID-19 infection (Figure 1 ). The response rate among all participants countrywide was 66% (3667/5567), where 97% (636/655) was from symptomatic individuals and 63% (2186/3470) was from asymptomatic individuals. Among the asymptomatic individuals, the response rate was 59% (845/1442) from symptomatic households and 71% (2186/3470) from asymptomatic households. The reasons for non-response were unavailability at home during data collection or unwillingness to provide swab samples.

After adjusting the sampling weight, we estimated, 12.6% (n=160) of the households had ≥1 COVID-19 infected individual. Among them, 0.9% (n=404) individuals had at least one COVID-19 like symptom at the national level, where urban (1.2%, n=113) population had more symptomatic individuals than rural (0.9%, n=234, p=0.17).

The estimated point prevalence of COVID-19 was nationally 6.4% (CI:4.2-9.7) ( Table-2 ). The prevalence rate was not significantly (p=0.30) different among the rural (7%, CI: 4.1-11.4) population and the urban (5%, CI: 3.3-7.2) population (Table-3 ). The prevalence rate was equal (p=0.52) among females (6.9%, CI: 4.1-11.6) and the males (5.9%, CI:3.8-9.0) ( Table-2 ). The Page 11 of 27 COVID-19 prevalence was high (9.5%, CI:4.2-20.0) among the adolescents followed by individuals above 60 years (7.8%, CI: 2.9-19.1) ( Table-2) .

After weighting, most (74%) of the symptomatic COVID-19 positive cases had fever where it was 85% in the urban population and 69% in rural. We estimated that 55% of the survey population had cough (same for both urban and rural), 19% had sore throat, and 6% had shortness of breathing. The weighted prevalence of COVID-19 among the symptomatic individuals was 18% (CI:13-24) and among the asymptomatic individuals was 6.4% (CI: 4.1-9.6) ( Table-2 ). About 8.5% of individuals who were asymptomatic on the first day of sample collection later became symptomatic within 14 days of the COVID-19 test. Among all COVID-19 positive cases, 13% were symptomatic (showing symptoms between day-1 and day-14), and 87% were asymptomatic.

All the selected districts had at least one confirmed COVID-19 case except one district named Feni, located in the southwest part of the country. The highest positivity rate of COVID-19 was in Jamalpur (18%, 15/83) (Figure-2) . The number of COVID-19 cases showed an upward trend from April to May 2020 and an increasing trend from June to July 2020, then decreased between August to October 2020 throughout the study. The highest peak of COVID-19 cases was observed in June 2020 (Figure 3 ).

The estimated nationwide community-based prevalence of COVID-19 was 6.4% in Bangladesh between April and October 2020. The prevalence of COVID-19 was almost similar in the urban Page 12 of 27 (5%) areas and the rural (7%) areas. Asymptomatic COVID-19 cases were estimated to be high (87%) among the positive cases of COVID-19, among the study population all over the country.

The highest peak of COVID-19 cases was in June 2020, which was immediately after the end of the first nationwide restricted movement in Bangladesh.

Similar to other studies, we found fever as the prime symptom followed by cough in different countries Larsen et al., 2020; Michelen et al., 2020; Wang et al., 2020) including Bangladesh (Ali et al., 2021; Chowdhury et al., 2021) . Reports from China have shown that four of five COVID-19 confirmed cases were asymptomatic (Day, 2020) , and a metaanalysis showed that 93% of the cases were asymptomatic (Kronbichler et al., 2020) , which is comparable to our study. However, our findings on high prevalence of asymptomatic cases were different than the other studies conducted in Bangladesh, as those studies found 11% to 19% of the cases were asymptomatic (Ali et al., 2021; Chowdhury et al., 2021; Mannan et al., 2021) .

However, all these studies were hospital based, and most of the asymptomatic cases may not have visited health care facilities (Gibbons et al., 2014) . An estimation of the Integrated Disease Surveillance Programme (IDSP) of India reported that 80% of COVID-19 were asymptomatic cases (Gosh, 2020; Munster et al., 2020) , However, most of the available studies estimated asymptomatic prevalence based on small data sets and findings from other studies conducted in specific settings. To the best of our knowledge, large empirical community-based studies detecting asymptomatic cases remain limited. The noticeable prevalence of asymptomatic cases identified in our study suggests that asymptomatic cases may be responsible for the salient transmission of COVID-19 at the community level.

As observed in our study, an increasing trend of COVID-19 prevalence in June 2020 was also observed in the database of the Government of Bangladesh (Siam et al., 2020) , and other studies Page 13 of 27 in Bangladesh (Hridoy et al., 2020; M. H. B. Siam et al., 2021) . The Government of Bangladesh executed a 66 day nationwide restricted movement policy from March 26 to May 31, 2020 (Siam et al., 2020) . The upward trend of COVID-19 prevalence in June indicates that the increased movement of people in June may have contributed to the increasing prevalence of cases. This underscored the fact that enforcement of social distancing measures may help control the spread of COVID-19 infection in densely populated settings, particularly when the asymptomatic cases are prevalent within the community settings.

Our study found similar infection rates among males and females, which matches the WHO age and sex disaggregation global findings of COVID-19 cases (World Health Organization, 2020).

Furthermore, studies noted similar susceptibility between males and females .

However, the database of the Government of Bangladesh showed a high prevalence of COVID-19 among males compared to females (Siam et al., 2020) , which might be linked to the prioritization of men in health care-seeking practices in the Bangladeshi context (Ahmed et al., 2001; Chen et al., 1981; Najnin et al., 2011) . Thus, men might have sought more care from the government COVID-19 reporting system. In our study, all members of the households were approached to participate. Thus, the difference between our study findings and the government dataset might explain the prevailing social and contextual gender role in Bangladesh.

The present study had several limitations. We collected specimens for testing from selected asymptomatic households instead of selecting all the asymptomatic households due to resource and time limitations. However, this limitation was addressed by presenting the weighted prevalence of COVID-19 (including symptomatic and asymptomatic cases). The other limitation was that we could not test a high proportion of asymptomatic individuals due to refusal and unavailability during data collection. Thus, interpretation of the prevalence of asymptomatic Page 14 of 27 COVID-19 cases should be considered with caution. However, our study's findings were similar to the reported Prevalence of COVID-19 cases in other settings (Day, 2020; Gosh, 2020; Kronbichler et al., 2020) .

Furthermore, our study is not beyond the limitation of response bias, and participants might have withheld their symptoms due to stigma, panic, or fear resulting from the massive dissemination of information through media (Ahmad & Murad, 2020; Hasan, 2020) . Furthermore, this study presented findings from 2020, whereas, many COVID-19 studies based on recent findings have already been published in Bangladesh (Chowdhury et al., 2021; Hridoy et al., 2020; Islam et al., 2021; Sarkar et al., 2021; M. H. B. Siam et al., 2021) . Nevertheless, to the best of our knowledge, this was the first attempt to estimate community prevalence of COVID-19 from a community-based cross-sectional study using large sample size with rigorous methodology in a low and middle-income (LMIC) country like Bangladesh to guide the epidemic control efforts of COVID-19 and provide scope for future research endeavours.

The estimation of point prevalence of COVID-19, including symptomatic and asymptomatic point prevalence in Bangladesh, provides us with an understanding of the COVID-19 transmission and an insight into the epidemic spread. The substantially high number of asymptomatic cases suggests that community-level containment and mitigation measures are required to combat COVID-19. In future studies, estimating basic reproduction number (R 0 ) for symptomatic and asymptomatic COVID-19 infection will be helpful to understand the transmission capability of SARS-CoV-2 and help define mitigation and control measures. 

The impact of social media on panic during the COVID-19 pandemic in Iraqi Kurdistan: online questionnaire study

Neonatal morbidity and care-seeking behaviour in rural Bangladesh

Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience

How will country-based mitigation measures influence the course of the COVID-19 epidemic? The Lancet

Presumed asymptomatic carrier transmission of COVID-19

COVID-19-New Insights on a Rapidly Changing Epidemic

Sex bias in the family allocation of food and health care in rural Bangladesh. Population and development review

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Analysis of the primary presenting symptoms and hematological findings of COVID-19 patients in Bangladesh

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19

Covid-19: four fifths of cases are asymptomatic, China figures indicate

Directorate General of Health Services)

Location and Area: The wards and area of North City Corporation

Location and Area: The wards and area of South City Corporation

A systematic review of asymptomatic infections with COVID-19

Bangladesh: First cases of COVID-19 confirmed March 8

Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods

80% Covid patients in India are asymptomatic, health ministry analysis finds

Global and local mutations in Bangladeshi SARS-CoV-2 genomes

The clinical feature of silent infections of novel coronavirus infection (COVID-19) in Wenzhou

Forecasting COVID-19 Dynamics and Endpoint in Bangladesh: A Data-driven Approach

Spatiotemporal patterns and trends of community transmission of the pandemic COVID-19 in South Asia: Bangladesh as a case study

Transmission Dynamics and Contact Tracing Assessment of COVID-19 in Chattogram, Bangladesh and Potential Risk of Close Contacts at Different Exposure Settings

Gender Differences in Patients With COVID-19: Focus on Severity and Mortality

Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19

Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis

Modeling the onset of symptoms of COVID-19. Front public health

Prevalence and clinical features of 2019 novel coronavirus disease (COVID-19) in the Fever Clinic of a teaching hospital in Beijing: a single-center, retrospective study

A multi-centre, cross-sectional study on coronavirus disease 2019 in Bangladesh: clinical epidemiology and short-term outcomes in recovered individuals

Epidemiology of Covid-19 in a longterm care

In patients of COVID-19, what are the symptoms and clinical features of mild and moderate cases

A novel coronavirus emerging in China-key questions for impact assessment

Inequalities in care-seeking for febrile illness of under-five children in urban Dhaka

Coronavirus Infections-More Than Just the Common Cold

Transmission of 2019-nCoV infection from an asymptomatic contact in Germany

Spatial modeling of COVID-19 transmission in Bangladesh

Insights into the first wave of the COVID-19 pandemic in Bangladesh: Lessons learned from a high-risk country

Insights into the first seven-months of COVID-19 pandemic in Bangladesh: lessons learned from a high-risk country

Dynamics of COVID-19 transmission in Dhaka and Chittagong: Two business hubs of Bangladesh

Community prevalence of SARS-CoV-2 among patients with influenzalike illnesses presenting to a Los Angeles

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

Gender and COVID-19: advocacy brief

WHO Coronavirus Disease (COVID-19) Dashboard. Retrieved October 5 from

A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period

SARS-CoV-2 viral load in upper respiratory specimens of infected patients

We are grateful to all the study participants for their valuable time and inputs. We are also thankful to Md. Altaf Riaj, Mohammad Ariful Islam, Farhad Hossain Akand, and Md.Khalekuzzaman for their contribution to data collection for this study. This study was funded by the United States Agency for International Development (USAID) and Bill and Melinda Gates Foundation (BMGF). icddr,b acknowledges with gratitude the commitment of USAID and BMGF to its research efforts. icddr,b is also grateful to the governments of Bangladesh, Canada, Sweden, and the United Kingdom for providing core/unrestricted support to icddr,b.

This research was supported by the US Agency for International Development (USAID, GR-01909) and Bill & Melinda gates foundation, Seattle, WA (BMGF, GR-01936).

There was no conflict of interested reported by any author.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.Page 16 of 27